Amgen to Build Generative AI Models for Novel Human Data Insights and Drug Discovery

	Amgen to Build Generative AI Models for Novel...

Generative AI is transforming drug research and development, enabling new discoveries faster than ever — and Amgen, one of the world’s leading biotechnology companies, is tapping the technology to power its research. Amgen will build AI models trained to analyze one of the world’s largest human datasets on an NVIDIA DGX SuperPOD, a full-stack data Read article >

- View Press Release
- Visit NVIDIA Corporation

Posted: January 8, 2024 | By: Wissen Schwamm

Recent NVIDIA related news.

Ready Player Fun: GFN Thursday Brings Six New Adventures to the Cloud

Into the Omniverse: How OpenUSD-Based Simulation and Synthetic Data Generation Advance Robot Learning

Built for the Era of AI, NVIDIA RTX AI PCs Enhance Content Creation, Gaming, Entertainment and More

Driving Mobility Forward, Vay Brings Advanced Automotive Solutions to Roads With NVIDIA DRIVE AGX

Turn Down the Noise: CUDA-Q Enables Industry-First Quantum Computing Demo With Logical Qubits

+ View more NVIDIA related news +

			More Technical Information Than You Can Handle.

Amgen to Build Generative AI Models for Novel...